Stayble Therapeutics AB (publ) (STO:STABL)
Sweden
· Delayed Price · Currency is SEK 0.174
-0.004 (-2.47%)
At close: Mar 6, 2026
Stayble Therapeutics AB Employees
Stayble Therapeutics AB had 2 employees as of December 31, 2024. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
23.50K SEK
Profits / Employee
-3.46M SEK
Market Cap
11.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 0 | - |
| Dec 31, 2021 | 3 | 1 | 50.00% |
| Dec 31, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| NanoEcho AB | 6 |
| Fluicell AB | 11 |
| Novakand Pharma AB | 5 |
| Aptahem AB | 3 |
| ExpreS2ion Biotech Holding AB | 20 |
| Lipigon Pharmaceuticals AB | 7 |
| Guard Therapeutics International AB | 12 |
| Modus Therapeutics Holding AB | 2 |